Brii Biosciences
North America, North Carolina, United States, Durham
Description
Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.
Investor Profile
Brii Biosciences has made 3 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (67%)
- Post Ipo Equity (33%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Clinical Trials
- Biopharma
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
